| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.kimiabiosciences.com | |
| Market Cap | 184.52 Cr. | |
| Enterprise Value(EV) | 225.09 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -0.78 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 32.02 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 3.15 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 12.39 | Calculated using Price: 39.00 |
| Dividend Yield | 0.00 | Period Ending 2021-03 |
| No. of Shares Subscribed | 4.73 Cr. | 47,312,741 Shares |
| FaceValue | 1 | |
| Company Profile | ||
| The company is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets. | ||
| 1 Day |
|
-0.26% |
| 1 Week |
|
-6.02% |
| 1 Month |
|
+7.88% |
| 3 Month |
|
+1.83% |
| 6 Month |
|
-11.96% |
| 1 Year |
|
-16.22% |
| 2 Year |
|
+12.39% |
| 5 Year |
|
+76.87% |
| 10 Year |
|
| 9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 62.28 | -34.59 | -166.09 | 243.83 | 16.47 | 32.19 | ||||
| Return on Capital Employed (%) | 43.72 | -23.86 | -135.77 | -216.82 | -18.30 | 11.83 | 16.94 | 8.94 | 16.13 | |
| Return on Assets (%) | 20.12 | -13.60 | -33.62 | -92.83 | -11.72 | 4.76 | 6.24 | 1.83 | 5.31 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
| Shh. Funds | 3 | 2 | 0 | -4 | -5 | 2 | 6 | 13 | 18 | 15 | |
| Non Curr. Liab. | 1 | 1 | 1 | 7 | 9 | 25 | 29 | 34 | 37 | 32 | |
| Curr. Liab. | 2 | 2 | 3 | 1 | 7 | 31 | 30 | 39 | 51 | 62 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 6 | 6 | 5 | 4 | 12 | 58 | 65 | 86 | 107 | 109 | |
| Non Curr. Assets | 4 | 4 | 4 | 4 | 10 | 15 | 18 | 25 | 35 | 36 | |
| Curr. Assets | 2 | 1 | 1 | 1 | 2 | 43 | 48 | 61 | 72 | 73 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 6 | 6 | 5 | 4 | 12 | 58 | 65 | 86 | 107 | 109 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
| Net Sales | 12 | 6 | 2 | 0 | 1 | 76 | 94 | 106 | 133 | 131 | |
| Other Income | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | |
| Total Income | 12 | 7 | 2 | 0 | 2 | 77 | 95 | 107 | 135 | 132 | |
| Total Expenditure | -10 | -7 | -4 | -4 | -2 | -74 | -88 | -102 | -124 | -129 | |
| PBIDT | 2 | 0 | -1 | -3 | 0 | 3 | 7 | 5 | 11 | 3 | |
| Interest | 0 | 0 | 0 | -1 | 0 | -1 | -2 | -3 | -3 | -4 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -2 | -2 | -3 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| Exceptional Items | |||||||||||
| PAT | 1 | -1 | -2 | -4 | -1 | 2 | 4 | 1 | 5 | -3 | |
| Adjusted EPS | 2 | -1 | -2 | -5 | -1 | 1 | 3 | 0 | 1 | -1 |
| Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 2 | 1 | 1 | 0 | -6 | -1 | -7 | -3 | 0 | 6 | |
| Cash Fr. Inv. | -1 | -1 | 0 | 0 | 0 | -6 | -2 | -2 | -9 | -14 | |
| Cash Fr. Finan. | -1 | -1 | 0 | 0 | 6 | 7 | 10 | 4 | 8 | 8 | |
| Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
|
Tue, 16 Aug 2022
Submission Of Newspaper Cuttings Of Financial Results For The Quarter And Three Months Ended On June 30 2022 Dear Sir Pursuant to Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith a copy of unaudited Financial Results (Standalone) for the quarter and three months ended June 30 2021 as published in Financial Express (English) and Jansatta (Hindi) on August 13 2022 duly considered and approved by the Board of Directors in its meeting held on Friday August 12 2022 at 4:00 p.m (IST) at corporate office of the Company.Kindly take the above information on your record. |
|
Fri, 12 Aug 2022
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) Dear Sir/ Maam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that that Ms. Arti Chief Financial Officer of Kimia Biosciences Limited (theCompany) has resigned from the Company with effect from 12"" August 2022 due to her personalreasons. The Requisite disclosure required in pursuance of SEB] Circular CIR/CFD/CMD/4/2015 dated09 September 2015 is annexed herewith.The new Chief Financial Officer will be appointed in due course of time by the Company. |
|
Fri, 12 Aug 2022
Board Meeting Outcome for Board Outcome Along With Un-Audited Standalone Financial Results For The Quarter And Three Months Ended June 30 2022 The meeting of Board of Directors of the Company was held today on Friday August 12 2022 at 4.00 P.M IST at the Corporate Office of the Company situated at 974 9th Floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitam Pura New Delhi-110034. |
| Fri, 12 Aug 2022 |
High Delivery Percentage
|
High Increase 1 Month
|
Doji and Near Doji
|
Bullish Harami Cross
|
| Thu, 11 Aug 2022 |
|
High Delivery Percentage
|
Equities
M.F.
Sectors